High School Students Have Made Martin Shkreli’s $750 Drug For Just $2
Last year, hedge-fund-manager-turned-pharmaceutical-company-CEO Martin Shkreli outraged the world by increasing the price of an essential drug. He acquired the U.S. rights to the lifesaving anti-parasitic drug Daraprim and raised the price by more than 5,000%…from $13.50…